Strategies to Overcome the Enzymatic Barrier-Reference-Cited by-同舟云学术

Strategies to Overcome the Enzymatic Barrier

Published:2009 Issue: Volume: Page:65-83
ISSN:
Container-title:Oral Delivery of Macromolecular Drugs
language:
Short-container-title:

Author:

Werle Martin,Takeuchi Hirofumi

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-0200-9_4.pdf

Reference61 articles.

1. Bernkop-Schnürch A, Fragner R (1996) Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration. Pharm Sci 2:361–363

2. Bernkop-Schnürch A, Göckel NC (1997) Development and analysis of a polymer protecting from luminal enzymatic degradation caused by a-chymotrypsin. Drug Dev Ind Pharm 23:733–740

3. Bernkop-Schnürch A, Kast CE, Guggi D (2003) Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer / GSH systems. J Control Release. 2003 Dec 5; 93(2):95–103.

4. Bernkop-Schnürch A (1998) The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release 52(1-2):1–16.

5. Bernkop-Schnürch A, Krajicek ME (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Control Rel 50:215–223

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selected Factors Affecting Oral Bioavailability of Nanoparticles Surface-Conjugated with Glycocholic Acid via Intestinal Lymphatic Pathway;Molecular Pharmaceutics;2020-10-16

2. Advanced Approaches of Bioactive Peptide Molecules and Protein Drug Delivery Systems;Current Pharmaceutical Design;2019-03-28

3. Peroral peptide delivery: Peptidase inhibition as a key concept for commercial drug products;Bioorganic & Medicinal Chemistry;2018-06

4. Microencapsulation of insulin and its release using w/o/w double emulsion method;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2017-05

5. Intestinal permeation enhancers for oral peptide delivery;Advanced Drug Delivery Reviews;2016-11